Louisiana State Employees Retirement System Takes $2.46 Million Position in Chemed Co. (NYSE:CHE)

Louisiana State Employees Retirement System purchased a new position in Chemed Co. (NYSE:CHEFree Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 4,200 shares of the company’s stock, valued at approximately $2,456,000.

A number of other institutional investors also recently bought and sold shares of CHE. Rice Hall James & Associates LLC bought a new position in Chemed in the first quarter worth about $273,000. Raymond James Financial Services Advisors Inc. raised its stake in Chemed by 13.3% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 1,957 shares of the company’s stock worth $992,000 after buying an additional 230 shares in the last quarter. American Century Companies Inc. raised its stake in Chemed by 7.2% in the first quarter. American Century Companies Inc. now owns 2,018 shares of the company’s stock worth $1,022,000 after buying an additional 135 shares in the last quarter. HighTower Advisors LLC raised its stake in Chemed by 6.2% in the first quarter. HighTower Advisors LLC now owns 836 shares of the company’s stock worth $432,000 after buying an additional 49 shares in the last quarter. Finally, Panagora Asset Management Inc. raised its stake in Chemed by 495.0% in the first quarter. Panagora Asset Management Inc. now owns 2,261 shares of the company’s stock worth $1,145,000 after buying an additional 1,881 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the sale, the executive vice president now owns 20,760 shares in the company, valued at $13,320,654. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, CFO Michael D. Witzeman sold 2,650 shares of the stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $643.14, for a total transaction of $1,704,321.00. Following the sale, the chief financial officer now owns 2,882 shares in the company, valued at $1,853,529.48. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Spencer S. Lee sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the sale, the executive vice president now owns 20,760 shares in the company, valued at approximately $13,320,654. The disclosure for this sale can be found here. Insiders have sold a total of 15,808 shares of company stock worth $10,184,531 over the last 90 days. 3.80% of the stock is currently owned by insiders.

Chemed Stock Performance

Shares of CHE opened at $608.40 on Wednesday. The stock has a market cap of $9.20 billion, a PE ratio of 33.95, a price-to-earnings-growth ratio of 2.48 and a beta of 0.42. Chemed Co. has a fifty-two week low of $492.84 and a fifty-two week high of $654.62. The firm’s 50-day simple moving average is $621.48 and its two-hundred day simple moving average is $587.18.

Chemed (NYSE:CHEGet Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $6.60 earnings per share for the quarter, topping analysts’ consensus estimates of $6.25 by $0.35. Chemed had a net margin of 12.03% and a return on equity of 32.29%. The business had revenue of $585.90 million for the quarter, compared to analysts’ expectations of $586.64 million. During the same quarter in the prior year, the company earned $5.39 earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. Equities research analysts predict that Chemed Co. will post 21.99 EPS for the current year.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date was Friday, February 23rd. Chemed’s payout ratio is 8.93%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CHE. Oppenheimer upped their price objective on shares of Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Thursday, February 29th. Royal Bank of Canada upped their price objective on shares of Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a report on Monday, March 4th.

View Our Latest Research Report on Chemed

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Articles

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.